Genematrix, acquires COVID-19 vaccine substitute materials and secured superior neutralizing antibodies for commercial vaccines 페이지 정보 작성일 21-10-05 00:00 목록 본문 - 관련링크 http://www.mdtoday.co.kr/mdtoday/index.html?no=431347 169회 연결 Genematrix, New product NeoPlex™ HPV 29 detection kit is CE certified 21.10.12 Genematrix, Acquires U.S. Patent for C-Tag™ Technology 21.09.08
ENG